Need help hiring top legal talent? Contact our team.
This job is expired. See open roles here
Company logo

Commercial Counsel

$216,000- $281,000/ year
Posted Mar 10
Full Time
RemoteSan Diego, California

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

Kura’s Legal Department is seeking an experienced and business-minded attorney to provide contracting, product and compliance counsel for the commercialization of Kura’s lead product candidate. This role will primarily support Kura’s Commercial, Medical Affairs and Chemistry, Manufacturing & Controls (CMC) Departments. Qualified candidates will have experience with at least one pharmaceutical product launch.


  • Draft, review and negotiate a broad range of agreements related to the commercialization of Kura’s lead product candidate, including:
    • commercial manufacturing, supply and 3PL agreements,
    • agreements with public and private payers, PBMs, GPOs and specialty pharmacies,
    • agreements with healthcare professionals and providers, including advisory board agreements and speaker bureau agreements, and
    • services agreements.
  • Serve as an internal subject matter expert and provide guidance to internal stakeholders on laws relating to the commercialization of pharmaceutical products in the U.S., including FDA regulations and anti-kickback, fraud and abuse and anti-bribery laws.
  • Provide legal guidance on strategies, programs, initiatives and contracts related to sales, marketing, market access, patient advocacy and patient assistance.
  • Provide advice on pharmaceutical pricing, reimbursement, price transparency and government price reporting requirements, and support related activities.
  • Provide guidance on speaker bureau and advisory board participation and other activities conducted by healthcare professionals at the request of the company.
  • Review and provide legal guidance on financial and other interactions with healthcare professionals, patients and others in a position to influence healthcare decisions (e.g., payers, advocacy groups, wholesalers/distributors, healthcare institutions) to ensure compliance with applicable laws and regulations.
  • Advise on legal issues related to state licensing, trade, distribution, notification and reporting requirements, and support related activities.
  • Provide guidance to internal stakeholders on the interpretation of applicable laws and regulations in a manner that provides practical legal advice and supports business objectives and priorities while appropriately managing risk to the organization.
  • Monitor new and revised laws, regulations, guidance documents, industry standards and enforcement actions related to drug product commercialization, and analyze and communicate the relevance of such updates to the business appropriately.
  • Develop policies and training materials to support compliance with laws relating to the commercialization of pharmaceutical products.
  • Develop contract templates for speaker bureaus, payers and other pre-commercial and commercial activities.

Job Requirements

  • Law degree and admission to at least one State Bar (required).
  • A minimum of 10 years of in-house and/or law firm experience providing legal advice and counseling on commercial contracting and pharmaceutical commercialization (in-house experience preferred).
  • Experience with at least one pharmaceutical product launch.
  • Thorough knowledge of pharmaceutical/biotechnology industry and laws, regulations, and guidelines applicable to the development and commercialization of medicinal products, including the Food, Drug and Cosmetic Act, Anti-Kickback Statute, False Claims Act and the Physician Payments Sunshine Act.
  • Strong critical thinking skills and the ability to grasp important business and legal issues and to appropriately balance risk mitigation with corporate objectives and priorities.
  • Outstanding interpersonal and leadership skills, with the ability to build strong relationships across functions and to communicate effectively with senior business leaders, as well as other professionals and colleagues at all levels of an organization.
  • Capacity to manage a significant number of projects simultaneously and to thrive in a dynamic and fast-paced environment.
  • Strong attention to detail.
  • Proven ability to work successfully both independently and as part of a highly collaborative team. 
  • Ability to analyze and interpret legal issues and develop and implement appropriately responsive strategies and solutions.

The base range for a Director is $216,000 - $281,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

Kura’s Values that are used for candidate selection and performance assessments:

  • We work as one for patients
  • We are goal-focused and deliver with excellence
  • We are science-driven courageous innovators
  • We strive to bring out the best in each other and ourselves

The Kura Package

  • Career advancement/ development opportunities
  • Competitive comp package
  • Bonus
  • 401K + Employer contributions
  • Generous stock options
  • ESPP Plan
  • 20 days of PTO to start
  • 18 Holidays  (Including Summer & Winter Break)
  • Generous Benefits Package with a variety of plans available with a substantial employer match
  • Paid Paternity/Maternity Leave
  • In-Office Catered lunches
  • Home Office Setup
  • Lifestyle Spending Stipend
  • Commuter Stipend (Boston Office)
  • Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.

Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment of genetically defined AML patients with high unmet need. Ziftomenib is currently enrolling patients in a Phase 2 registration-directed trial (KOMET-001) in NPM1-mutant relapsed or refractory AML. Kura is preparing to initiate multiple Phase 1 trials to evaluate ziftomenib in combination with current standards of care in earlier lines of therapy and across multiple patient populations, including NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective FTI, is currently in a Phase 1/2 trial (KURRENT-HN) in combination with alpelisib for patients with PIK3CA-dependent HNSCC. Kura intends to evaluate KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial (FIT-001) as a monotherapy and in combination with other targeted therapies in adult patients with advanced solid tumors. For additional information, please visit Kura’s website at

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.

Similar Opportunities